Drug Discovery with 65,000 Processors

In this video, the University of Tennessee at Knoxville's Cynthia Peterson discusses an Integrated Graduate Education and Research Training Program project for Scalable Computing and Leading Edge Innovative Technologies for Biology.

Peterson's particular area of focus within this project is to develop a supercomputing-based research tool based on validated and widely used docking approaches adapted for high-throughput screening of millions of compounds in a single day. With virtual screening, target protein computations can now be run on over 65,000 processors or more in parallel on a supercomputer, completing what typically took several weeks in one day.

Matthew Dublin is a senior writer at Genome Technology.